These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30202729)

  • 21. [Daptomycin therapy in patients with bacteremia].
    Llinares P; Iribarren JA
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():17-25. PubMed ID: 22541971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Daptomycin-Induced Cellular Membrane Injury in Skeletal Muscle.
    Yamada T; Ishikawa S; Ishiguro N; Kobayashi M; Iseki K
    Biol Pharm Bull; 2020 Sep; 43(9):1338-1345. PubMed ID: 32581153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftaroline Plus Daptomycin for Refractory Methicillin- Resistant Staphylococcus aureus Bacteremia in a Child.
    Hall AM; McTigue SM
    J Pediatr Pharmacol Ther; 2018; 23(6):490-493. PubMed ID: 30697136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.
    Skiest DJ
    J Clin Microbiol; 2006 Feb; 44(2):655-6. PubMed ID: 16455939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
    Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR; Havill NL; Koeth LM; Boyce JM
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
    Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury.
    Nishimura Y
    Cureus; 2022 Sep; 14(9):e29764. PubMed ID: 36324366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Septic Thrombophlebitis with Persistent Methicillin-Resistant
    Koton Y; Or Z; Bisharat N
    Infect Dis Rep; 2017 May; 9(2):7008. PubMed ID: 28626538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.
    Claeys KC; Smith JR; Casapao AM; Mynatt RP; Avery L; Shroff A; Yamamura D; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1969-76. PubMed ID: 25605354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Segreti JA; Crank CW; Finney MS
    Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Timbrook TT; Caffrey AR; Luther MK; Lopes V; LaPlante KL
    Pharmacotherapy; 2018 Feb; 38(2):189-196. PubMed ID: 29235661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.